
Opinion|Videos|April 21, 2025
Assessing the Quality of Recommendations and Making Clinical Decisions About Lp(a) Testing
Experts discuss whether providers should wait for another complete scientific statement from the National Lipid Association (NLA) or new guidelines from organizations like the American Heart Association (AHA) before implementing the 2024 NLA recommendation for universal lipoprotein(a) (Lp[a]) measurement.
Advertisement
Video content above is prompted by the following:
The NLA’s 2024 recommendation comes as a “focused update” to its 2019 scientific statement on the use of Lp(a) in clinical practice. Should providers wait for another complete scientific statement from NLA—or for new guidelines from AHA or other organizations—before implementing this recommendation?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Giredestrant Regimen for ESR1-Mutated Breast Cancer
2
Hepatitis B Screening Gaps Persist as Functional Cure Option Arrives
3
IgA Nephropathy, FSGS Care Needs Coordinators, Not Just New Drugs
4
FDA Approves Secukinumab as First Anti–IL-17 Biologic for PMR
5


